Plantable Health Inc.
PLBL.NE · NEO
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.01 | 0.95 | 0.00 |
| FCF Yield | -599.00% | -6.25% | -0.81% | -2.54% |
| EV / EBITDA | -0.08 | -13.83 | -86.87 | -34.47 |
| Quality | ||||
| ROIC | -508.13% | -41.92% | 1,418.74% | -721.10% |
| Gross Margin | 24.20% | 16.32% | 18.99% | 3.91% |
| Cash Conversion Ratio | 0.92 | 0.28 | 0.34 | 0.58 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.79% | 4.61% | 1,044,843.79% | 992,456.74% |
| Free Cash Flow Growth | -113.06% | -680.56% | 71.94% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.08 | 2.43 | -4.89 | -1.17 |
| Interest Coverage | -364.69 | -22.44 | -1.66 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 12.14 | 12.77 | 19.53 | 25.85 |
| Cash Conversion Cycle | 19.70 | -38.96 | 15.99 | 7.13 |